Join the Canadian researchers as they take apart the recent decision by Avrobio to cancel their program for the development of a gene therapy for Fabry patients. This decision was made based on a number of considerations, read more here: https://www.socialpharmaceuticalinnovation.org/post/a-gene-therapy-for-fabry-patients-a-derelict-dream
Please share any thoughts you have on this with us below!